Scott Thacher, a research director at Irvine-based biotech firm Allergan, could see his company was not going to pursue development of several new drugs he and his division were working on, yet he realized the market for such drugs was huge...

Take 1 minute to subscribe and you'll get this story immediately, plus:

Already a subscriber? Sign in

  • 52 weekly issues
  • Subscriber-only digital content every business day, plus full access to archives
  • Book of Lists — the most comprehensive business resource in San Diego
  • San Diego 500 — influential business leaders you need to know
Yours for only $129